老年心房颤动伴二尖瓣反流患者的临床特点和预后

刘美, 范琰, 刘梅林. 老年心房颤动伴二尖瓣反流患者的临床特点和预后[J]. 临床心血管病杂志, 2021, 37(5): 447-452. doi: 10.13201/j.issn.1001-1439.2021.05.011
引用本文: 刘美, 范琰, 刘梅林. 老年心房颤动伴二尖瓣反流患者的临床特点和预后[J]. 临床心血管病杂志, 2021, 37(5): 447-452. doi: 10.13201/j.issn.1001-1439.2021.05.011
LIU Mei, FAN Yan, LIU Meilin. Clinical manifestation and prognosis of atrial fibrillation with mitral regurgitation in the elderly[J]. J Clin Cardiol, 2021, 37(5): 447-452. doi: 10.13201/j.issn.1001-1439.2021.05.011
Citation: LIU Mei, FAN Yan, LIU Meilin. Clinical manifestation and prognosis of atrial fibrillation with mitral regurgitation in the elderly[J]. J Clin Cardiol, 2021, 37(5): 447-452. doi: 10.13201/j.issn.1001-1439.2021.05.011

老年心房颤动伴二尖瓣反流患者的临床特点和预后

  • 基金项目:

    北大百度基金资助项目(No:2019BD019)

    北京大学第一医院科研种子基金(No:2020SF22)

详细信息
    通讯作者: 刘梅林,E-mail:liumeilin@hotmail.com
  • 中图分类号: R541.7

Clinical manifestation and prognosis of atrial fibrillation with mitral regurgitation in the elderly

More Information
  • 目的:探讨老年心房颤动(房颤)伴功能性二尖瓣反流(MR)患者的临床特点和预后。方法:回顾性分析2012年8月—2019年12月于北京大学第一医院老年病内科住院并接受超声心动图检查的年龄≥65岁、房颤伴左房增大、二尖瓣运动及形态正常、MR患者的临床资料。根据MR程度,分为轻度、中度、重度3组,分析组间临床指标及超声心动图指标差异。随访记录全因死亡及因心力衰竭(心衰)再住院的事件,进行Kaplan-Meier生存分析和多因素Cox回归分析。结果:入选120例患者,中位年龄86岁。重度MR组女性、NYHAⅣ级占比明显高于轻度和中度MR,重度MR组左室射血分数明显低于轻度和中度MR组;重度MR组BMI明显低于轻度MR组;重度MR组脑钠肽、收缩期三尖瓣反流峰值速度、肺动脉收缩压明显高于轻度MR组。在中位时间为26个月的随访中,44例(38.9%)发生全因死亡,37例(32.7%)因心衰再住院。3组间全因死亡率、因心衰住院率有显著差异(Log Rank P=0.042、0.006)。随着MR程度增加,全因死亡率、因心衰再住院率增加(P<0.05)。多因素COX回归分析显示,NHYA分级(HR:1.924,95%CI:1.293~2.863,P=0.001)、MR程度(HR:1.717,95%CI:1.032~2.856,P=0.037)与因心衰再住院相关。结论:老年房颤伴功能性MR患者,随着MR程度增加,全因死亡率、因心衰再住院率增加。NYHA分级、MR程度是老年房颤患者因心衰再住院的危险因素。
  • 加载中
  • [1]

    Wang Z,Chen Z,Wang X,et al.The disease burden of atrial fibrillation in china from a national cross-sectional survey[J].Am J Cardiol,2018,122(5):793-798.

    [2]

    Ito K,Abe Y,Takahashi Y,et al.Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation:A study using three-dimensional transesophageal echocardiography[J].J Cardiol,2017,70(6):584-590.

    [3]

    Deferm S,Bertrand PB,Verbrugge FH,et al.Atrial functional mitral regurgitation:JACC Review Topic of the Week[J].J Am Coll Cardiol,2019,73(19):2465-2476.

    [4]

    Abe Y,Takahashi Y,Shibata T.Functional mitral regurgitation,updated:ventricular or atrial[J].J Echocardiogr,2020,18(1):1-8.

    [5]

    Abe Y,Akamatsu K,Ito K,et al.Prevalence and prognostic significance of functional mitral and tricuspid regurgitation despite preserved left ventricular ejection fraction in atrial fibrillation patients[J].Circ J,2018,82(5):1451-1458.

    [6]

    Gertz ZM,Raina A,Saghy L,et al.Evidence of atrial functional mitral regurgitation due to atrial fibrillation:reversal with arrhythmia control[J].J Am Coll Cardiol,2011,58(14):1474-1481.

    [7]

    Kim DH,Heo R,Handschumacher MD,et al.Mitral valve adaptation to isolated annular dilation:insights into the mechanism of atrial functional mitral regurgitation[J].JACC Cardiovasc Imaging,2019,12(4):665-677.

    [8]

    Gómez-Outes A,Lagunar-Ruíz J,Terleira-Fernández AI,et al.Causes of death in anticoagulated patients with atrial fibrillation[J].J Am Coll Cardiol,2016,68(23):2508-2521.

    [9]

    陈宏,周鹏,侯霁芯,等.射血分数保留心力衰竭的临床特征及预后因素分析[J].临床心血管病杂志,2018.34(10):1018-1023.

    [10]

    Nishimura RA,Otto CM,Bonow RO,et al.2017 AHA/ACC Focused Update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].J Am Coll Cardiol,2017,70(2):252-289.

    [11]

    Baumgartner H,Falk V,Bax JJ,et al.2017 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J,2017,38(36):2739-2791.

    [12]

    Kihara T,Gillinov AM,Takasaki K,et al.Mitral regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation:an echocardiographic study[J].Echocardiography,2009,26(8):885-889.

    [13]

    Silbiger JJ.Mechanistic insights into atrial functional mitral regurgitation:Far more complicated than just left atrial remodeling[J].Echocardiography,2019,36(1):164-169.

    [14]

    Kagiyama N,Hayashida A,Toki M,et al.Insufficient leaflet remodeling in patients with atrial fibrillation:association with the severity of mitral regurgitation[J].Circ Cardiovasc Imaging,2017,10(3):e005451.

    [15]

    Tang Z,Fan YT,Wang Y,et al.Mitral annular and left ventricular dynamics in atrial functional mitral regurgitation:a three-dimensional and speckle-tracking echocardiographic study[J].J Am Soc Echocardiogr,2019,32(4):503-513.

    [16]

    Ring L,Dutka DP,Wells FC,et al.Mechanisms of atrial mitral regurgitation:insights using 3D transoesophageal echo[J].Eur Heart J Cardiovasc Imaging,2014,15(5):500-508.

    [17]

    Kajimoto K,Sato N,Takano T.Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction[J].Eur J Heart Fail,2016,18(8):1051-1059.

    [18]

    Saito C,Minami Y,Arai K,et al.Prevalence,clinical characteristics,and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation[J].J Cardiol,2018,72(4):292-299.

    [19]

    朱文青,陈庆兴.《2020 ESC/EACTS心房颤动诊断与管理指南》更新解读[J].临床心血管病杂志,2020,36(11):975-977.

  • 加载中
计量
  • 文章访问数:  388
  • PDF下载数:  279
  • 施引文献:  0
出版历程
收稿日期:  2020-12-03

目录